frequentlyaskedquestionspre-exposureprophylaxis（5页）.docVIP

Frequently Asked Questions: Pre-Exposure Prophylaxis (PrEP) for HIV Infection Massachusetts Department of Public Health – Updated July 2013 On July 16, 2012, the Food and Drug Administration (FDA) approved the use of Truvada? (TDF/FTC) as pre-exposure prophylaxis (PrEP) for HIV-uninfected individuals at high risk for sexually acquired HIV infection. Clinical trials in several populations have demonstrated efficacy of TDF/FTC as PrEP to prevent HIV acquisition in HIV-unifected individuals when combined with counseling about safer sex and other risk reduction methods. On June 14, 2013, the